In:
Prenatal Diagnosis, Wiley, Vol. 44, No. 6-7 ( 2024-06), p. 796-803
Abstract:
What is already known about this topic? Fetal enlarged cavum septum pellucidum (CSP) and small thymus have been proposed as markers for 22q11.2 deletion syndrome, but there is limited data on their performance, particularly in fetuses with conotruncal heart disease. What does this study add? Data from this study strongly suggest that enlarged CSP and hypoplastic/absent thymus are components of the fetal phenotype of 22q11.2DS and can be used as markers to risk stratify fetuses with conotruncal heart defects.
Type of Medium:
Online Resource
ISSN:
0197-3851
,
1097-0223
Language:
English
Publisher:
Wiley
Publication Date:
2024
detail.hit.zdb_id:
82031-3
detail.hit.zdb_id:
1491217-X